Optimizing treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction: Opening windows to enhanced sexual function and overall health
Identifieur interne : 000034 ( Canada/Analysis ); précédent : 000033; suivant : 000035Optimizing treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction: Opening windows to enhanced sexual function and overall health
Auteurs : Richard Sadovsky [États-Unis] ; Gerald B. Brock [Canada] ; Mikel Gray [États-Unis] ; Penny Kaye Jensen [États-Unis] ; Stephen W. Gutkin [États-Unis] ; Sebastian Sorsaburu [États-Unis]Source :
- Journal of the American Academy of Nurse Practitioners [ 1041-2972 ] ; 2011-06.
Descripteurs français
- Wicri :
- topic : Contrôle des connaissances.
English descriptors
- KwdEn :
Abstract
Purpose: Phosphodiesterase type 5 (PDE5) inhibitors have proved to be efficacious, safe, and well tolerated, in clinical trials and practice, for men with erectile dysfunction (ED). However, many patients are not satisfied with treatment and discontinue it prematurely. This review discusses evidence‐based strategies that nurse practitioners (NPs) can use to improve diagnosis of ED, optimize patient outcomes, and identify opportunities to detect other potentially serious comorbid conditions.
Url:
DOI: 10.1111/j.1745-7599.2010.00590.x
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001384
- to stream Istex, to step Curation: 001381
- to stream Istex, to step Checkpoint: 000121
- to stream Main, to step Merge: 000296
- to stream Main, to step Curation: 000296
- to stream Main, to step Exploration: 000296
- to stream Canada, to step Extraction: 000034
Links to Exploration step
ISTEX:56297BF96D594B7B3EA523336A55CF21814D53FALe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Optimizing treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction: Opening windows to enhanced sexual function and overall health</title><author><name sortKey="Sadovsky, Richard" sort="Sadovsky, Richard" uniqKey="Sadovsky R" first="Richard" last="Sadovsky">Richard Sadovsky</name></author><author><name sortKey="Brock, Gerald B" sort="Brock, Gerald B" uniqKey="Brock G" first="Gerald B." last="Brock">Gerald B. Brock</name></author><author><name sortKey="Gray, Mikel" sort="Gray, Mikel" uniqKey="Gray M" first="Mikel" last="Gray">Mikel Gray</name></author><author><name sortKey="Jensen, Penny Kaye" sort="Jensen, Penny Kaye" uniqKey="Jensen P" first="Penny Kaye" last="Jensen">Penny Kaye Jensen</name></author><author><name sortKey="Gutkin, Stephen W" sort="Gutkin, Stephen W" uniqKey="Gutkin S" first="Stephen W." last="Gutkin">Stephen W. Gutkin</name></author><author><name sortKey="Sorsaburu, Sebastian" sort="Sorsaburu, Sebastian" uniqKey="Sorsaburu S" first="Sebastian" last="Sorsaburu">Sebastian Sorsaburu</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:56297BF96D594B7B3EA523336A55CF21814D53FA</idno><date when="2011" year="2011">2011</date><idno type="doi">10.1111/j.1745-7599.2010.00590.x</idno><idno type="url">https://api.istex.fr/document/56297BF96D594B7B3EA523336A55CF21814D53FA/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001384</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001384</idno><idno type="wicri:Area/Istex/Curation">001381</idno><idno type="wicri:Area/Istex/Checkpoint">000121</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000121</idno><idno type="wicri:doubleKey">1041-2972:2011:Sadovsky R:optimizing:treatment:outcomes</idno><idno type="wicri:Area/Main/Merge">000296</idno><idno type="wicri:Area/Main/Curation">000296</idno><idno type="wicri:Area/Main/Exploration">000296</idno><idno type="wicri:Area/Canada/Extraction">000034</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Optimizing treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction: Opening windows to enhanced sexual function and overall health</title><author><name sortKey="Sadovsky, Richard" sort="Sadovsky, Richard" uniqKey="Sadovsky R" first="Richard" last="Sadovsky">Richard Sadovsky</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>State University of New York Health Science Center at Brooklyn (SUNY Downstate Medical Center) and Kings County Hospital Center, Brooklyn</wicri:cityArea></affiliation></author><author><name sortKey="Brock, Gerald B" sort="Brock, Gerald B" uniqKey="Brock G" first="Gerald B." last="Brock">Gerald B. Brock</name><affiliation wicri:level="1"><country xml:lang="fr">Canada</country><wicri:regionArea>Division of Urology, Faculty of Medicine and Dentistry, University of Western Ontario, London, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Gray, Mikel" sort="Gray, Mikel" uniqKey="Gray M" first="Mikel" last="Gray">Mikel Gray</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Virginie</region></placeName><wicri:cityArea>Department of Urology, School of Nursing, University of Nursing, Charlottesville</wicri:cityArea></affiliation></author><author><name sortKey="Jensen, Penny Kaye" sort="Jensen, Penny Kaye" uniqKey="Jensen P" first="Penny Kaye" last="Jensen">Penny Kaye Jensen</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Utah</region></placeName><wicri:cityArea>Salt Lake City Veterans Affairs Medical Center & University of Utah College of Nursing, Salt Lake City</wicri:cityArea></affiliation></author><author><name sortKey="Gutkin, Stephen W" sort="Gutkin, Stephen W" uniqKey="Gutkin S" first="Stephen W." last="Gutkin">Stephen W. Gutkin</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">New Jersey</region></placeName><wicri:cityArea>Rete Biomedical Communications Corp., Wyckoff</wicri:cityArea></affiliation></author><author><name sortKey="Sorsaburu, Sebastian" sort="Sorsaburu, Sebastian" uniqKey="Sorsaburu S" first="Sebastian" last="Sorsaburu">Sebastian Sorsaburu</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Indiana</region></placeName><wicri:cityArea>Eli Lilly and Company, Indianapolis</wicri:cityArea></affiliation></author></analytic><monogr></monogr><series><title level="j">Journal of the American Academy of Nurse Practitioners</title><idno type="ISSN">1041-2972</idno><idno type="eISSN">1745-7599</idno><imprint><publisher>Blackwell Publishing Inc</publisher><pubPlace>Malden, USA</pubPlace><date type="published" when="2011-06">2011-06</date><biblScope unit="volume">23</biblScope><biblScope unit="issue">6</biblScope><biblScope unit="page" from="320">320</biblScope><biblScope unit="page" to="330">330</biblScope></imprint><idno type="ISSN">1041-2972</idno></series><idno type="istex">56297BF96D594B7B3EA523336A55CF21814D53FA</idno><idno type="DOI">10.1111/j.1745-7599.2010.00590.x</idno><idno type="ArticleID">JAAN590</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1041-2972</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Assessment</term><term>drug therapy</term><term>erectile dysfunction</term><term>phosphodiesterases</term><term>risk factors</term><term>sexual activity</term><term>treatment outcomes</term><term>vasoactive agents</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Contrôle des connaissances</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract">Purpose: Phosphodiesterase type 5 (PDE5) inhibitors have proved to be efficacious, safe, and well tolerated, in clinical trials and practice, for men with erectile dysfunction (ED). However, many patients are not satisfied with treatment and discontinue it prematurely. This review discusses evidence‐based strategies that nurse practitioners (NPs) can use to improve diagnosis of ED, optimize patient outcomes, and identify opportunities to detect other potentially serious comorbid conditions.</div></front></TEI><affiliations><list><country><li>Canada</li><li>États-Unis</li></country><region><li>Indiana</li><li>New Jersey</li><li>Utah</li><li>Virginie</li><li>État de New York</li></region></list><tree><country name="États-Unis"><region name="État de New York"><name sortKey="Sadovsky, Richard" sort="Sadovsky, Richard" uniqKey="Sadovsky R" first="Richard" last="Sadovsky">Richard Sadovsky</name></region><name sortKey="Gray, Mikel" sort="Gray, Mikel" uniqKey="Gray M" first="Mikel" last="Gray">Mikel Gray</name><name sortKey="Gutkin, Stephen W" sort="Gutkin, Stephen W" uniqKey="Gutkin S" first="Stephen W." last="Gutkin">Stephen W. Gutkin</name><name sortKey="Jensen, Penny Kaye" sort="Jensen, Penny Kaye" uniqKey="Jensen P" first="Penny Kaye" last="Jensen">Penny Kaye Jensen</name><name sortKey="Sorsaburu, Sebastian" sort="Sorsaburu, Sebastian" uniqKey="Sorsaburu S" first="Sebastian" last="Sorsaburu">Sebastian Sorsaburu</name></country><country name="Canada"><noRegion><name sortKey="Brock, Gerald B" sort="Brock, Gerald B" uniqKey="Brock G" first="Gerald B." last="Brock">Gerald B. Brock</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Psychologie/explor/TherFamFrancoV1/Data/Canada/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000034 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Canada/Analysis/biblio.hfd -nk 000034 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Psychologie
|area= TherFamFrancoV1
|flux= Canada
|étape= Analysis
|type= RBID
|clé= ISTEX:56297BF96D594B7B3EA523336A55CF21814D53FA
|texte= Optimizing treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction: Opening windows to enhanced sexual function and overall health
}}
| This area was generated with Dilib version V0.6.29. |  |